Updates and Future Directions
Edward Van Matre, BCCCP, MS, PharmD
Assistant Professor
University of Tennessee College of Pharmacy
Memphis, Tennessee
No relevant financial relationship(s) to disclose
Guidelines for vancomycin area under the curve (AUC)/minimum inhibitory concentration (MIC) monitoring were published by the Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and Society of Infectious Diseases Pharmacists in March 2020. Many institutions are developing new protocols for monitoring vancomycin, including updated recommendation from the guidelines to use AUC/MIC monitoring in place of traditional trough monitoring. In addition, recent literature has promoted the use of continuous-infusion beta-lactam dosing. In this flipped classroom session, attendees will bring local protocols and dosing schemes to launch a comparison with the newly published guidance and compare strategies by using audience polling. Advantages and disadvantages of two-level AUC pharmacokinetics and more advanced Bayesian AUC pharmacokinetics will be reviewed in an interactive session using simulated patient data, including initial dosing schemes and dosage revisions. A similar approach will be taken to determine time > MIC dosing for beta-lactam antibiotics using therapeutic drug monitoring techniques and extended/continuous-infusion dosing approaches.
Concurrent Session Faculty: Siu Yan Amy Yeung, BCCCP, BCPS, PharmD – University of Maryland Medical Center
Concurrent Session Faculty: Melissa Thompson Bastin, BCCCP, PharmD, PhD – University of Kentucky HealthCare